Self HarmNCT03768674
Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway
An observational study of Self Harm and Personality Disorders, run by Oslo University Hospital at 1 site in Norway.
Trial summary
Patients who self-harm are a heterogeneous population. Outpatient treatments structured for borderline personality disorder are often recommended and hospitalization kept to a minimum. However, few studies have focused on the most severe, complex conditions with extreme suicide risk. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Self Harm, Personality Disorders, Psychosis
- What is being tested?
- Assessment of diagnoses, functioning and health services
- How many people
- 1,640 participants
- Where
- 1 siteNorway
- Study dates
- 1 Oct 2019to 1 Sep 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Study population: The target population is patients with extensive hospitalization due to selfharming behaviors
Who may be able to join
- Admitted to inpatient units (adult psychiatry, mental health centres or hospitals) due to risk of severe self-harm.
- Duration of admissions either > 4 weeks and/or > five admissions preceding year.
- Assessed for outpatient treatment within the outpatient Network
Who cannot join
- Not inpatients at a psychiatric, adult (18-60 yrs) institution
- Assessed but not admitted to outpatient treatment within the Network
Trial locations and contacts
1 site in 1 country.
About this study
Official title: English Title: Extreme Challenges - Psychopathology, Treatment Organization and Experiences Among Psychiatric Inpatients With Severe Self-harming Behavior in Norway
Patients who self-harm are a heterogeneous population. Outpatient treatments structured for borderline personality disorder are often recommended and hospitalization kept to a minimum. However, few studies have focused on the most severe, complex conditions with extreme suicide risk. A recent national investigation from Norway (2017) demonstrated a far larger cohort of extensively hospitalized inpatients with extreme self-harming behaviors than was expected (N=427) - identified in all health regions. Reported challenges were high-risk situations, severe medical sequelae, difficult collaborations across services, and uncertainty about psychiatric diagnoses.
Severe, often bizarre, self-harm is thus a major challenge for both patients and health services. In hospitals, safety measures can involve restrictions and involuntary regimes. As research on this target population is sparse, the current project seeks further understanding of complex conditions - psychopathology, treatment experiences and service collaboration.
Read more
The project is a national, multi-center cooperation including patients in psychiatric hospitals in all health regions. It is cross sectional. Data is based on diagnostic interviews, patients' self-reported symptoms and both patients and service providers treatment experiences. The inclusion period for inpatients (N=300) and a comparison sample of outpatients (N=300) is one year.
The target group is inpatients with extreme hospitalization and severe self-mutilation. A comparison group is patients with personality pathology attending outpatient treatments. Recruitment is across health regions.
Aim 1: Investigate psychopathology of patients in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 2: Investigate personality functioning in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 3: a) Investigate health service use in the target population and compare to a clinical sample admitted to outpatient treatment.
- Investigate treatment experiences and health service collaborations in the target population.
The project will provide rational for future preventive treatment interventions
Read the detailed description
Design: A cross-sectional investigation. The inclusion period will be one year.
The target group: Patients admitted to inpatient units (adult psychiatry, mental health centres or hospitals) due to risk of severe self-harm. The duration of admissions are either more than 4 weeks and/or patients have had more than five admissions in the preceding year.
The comparison group is a collaboration with the Norwegian Network of personality-focused treatments and includes clinical data from 19 outpatient units within specialist mental health services across Norway (baseline data for 300 patients admitted to treatment during 2017-2018).
Sample size: An inclusion of N=300 patients in the target Group and comparison group
Assessments: The assessment battery combines therapist administered interviews and patient self-report measures to provide a broad differential-diagnostic evaluation and information about treatment and health-service collaborations. It also includes therapist-reports.
Psychopathology: Assessment of psychiatric disorders includes interviews for symptom disorders (MINI), personality traits and disorders (SCID-5-PD, and observer-evaluated global functioning (GAF) administered in both the target and the comparison group. Assessment of the target group will additionally include a screening interview on cognitive functioning (Hayes Ability Screening Index, HASI, specific approval has been given), self-report screening of autism (Ritvo Autisme Asperger Diagnoseskjema - Revidert RAADS-R), and a detailed interview on psychosis (questions from MINI plus).
General, social and personality functioning: The assessment battery includes a combination of well-established, (no cost) self-report measures covering overall functioning, symptoms, trauma, personality functioning and maladaptive behaviors. These will be administered in both the target and the comparison group. More details on assessment battery can be given on request to PI.
Self-harming behaviors: Self-report on self-harming behaviors and suicide attempts last 6 months are included. Assessment of the target group will additionally include a more detailed interview of self-harming behaviors adapted for Norwegian studies (Lifetime Para suicide Count).
Service use, treatment experiences, and health service collaborations: Assessment of previous treatments, age first time, and contact with child/adolescent psychiatry (self-report, both the target and the comparison group), and a detailed interview on medication, treatments, primary health care and welfare services last 6 months (specially designed interview, both target and comparison group). In addition, for the target group, questions about involuntary and restrictive regimes, treatment involvement, confidence, alliance and collaboration within and across health services are included (patient and therapist reported).
Research collaborators:
The PhD candidate will follow the PhD educationary program at the University of Oslo. Main supervisor is also Principle Investigator (E.H.Kvarstein), and co supervisor (G.Pedersen) heads the Network collaboration. The PhD candidate will join the national project group and be an associated member of the Research group for Personality Psychiatry.
The national project group is central in all phases; design, preparations, implementation procedures, evaluation, and presentations of results. It covers all health regions, relevant research environments, clinicians and users. It includes: Middle HR: T.Torgersen, PhD, Western HR: T.Tveit, MD. Southeastern HR: P.A.Ringen, PhD, P.Danielsen, MA, C.A.Sveen (MA), Tore Buer (MD). Northern HR: H.Tvete, MD, T.Høifødt, PhD. National Centre, Suicide Research and Prevention: F.Walby,MA, R.K.Ramleth, MD (BUP). Regional Centre, Violence and Traumatic Stress: I.Lunde, MA. Early intervention Psychosis: K.L.Romm, PhD. Personality Psychiatry National Advisory Unit: Ø.Urnes,MD. User experience: T.Røstbakken, M.Pettersen, A.Holst.
The Research group for personality psychiatry (University of Oslo/Oslo University Hospital) is an active, well-established research group with engagement in national and international research collaborations specializing on personality pathology and clinical research.
The principle investigator (PI) and main supervisor of this project, E.H.Kvarstein, associate professor, University of Oslo/ Head senior consultant, Section for Personality Psychiatry, Oslo University Hospital, is head of the Research group of personality psychiatry.
The Norwegian Network for personality-focused treatment is a well-established collaboration aiming to ensure clinical quality, systematic treatment evaluation and generate data for clinical research (anonymous data collection). The Network was established in 1993 and currently includes 19 outpatient treatment teams across Norway for patients with personality disorder. Approximately 400 patients are admitted to treatments within the Network each year (mean treatment duration: 2 years). The Network provides systems for patient assessment and progress evaluation, systematic feedback reports on clinical outcomes and supervision/seminars on diagnostic assessment and treatment. The main (ongoing) research project in the Network is a multi-centre feasibility investigation of evidence-based treatment for personality disorder (started in 2017) aiming to include longitudinal treatment data for 500 patients.
"Extreme challenges" is a research collaboration between the national project group and the Network. Baseline data from the multi-centre project constitute the outpatient comparison group in "Extreme challenges" (300 patients, admitted to outpatient treatment in 2017-18, data available in 2020).
Cosupervisor in the PhD project, head of the Network, is senior researcher Geir Pedersen. He is affiliated within the Section for Personality Psychiatry, Oslo University Hospital and the University of Oslo. He is a member of the research group.
Norwegian National Advisory Unit on Personality Psychiatry (NAPP) is the initiator of the current project and the organizer of the national project group. With the establishment of an expert user panel (recruiting users from the whole country), NAPP has also had an active role establishing user engagement in this project.
Plan for activities - practical implementation of the cross sectional investigation: The national project group has already completed a preliminary screening investigation, first publication, and designed the current project. The project group is currently preparing practical implementation of the project (mobilizing regional collaborators, local resource groups and finalizing ethic approvals and systems for data collection).
2018/19: Preparation: Regional preparatory seminars for local clinicians and all collaborators are scheduled to autumn 2019.
2019/2020: Data collection: Assessments of the target population will be performed at the inpatient institutions by local clinicians qualified for diagnostic procedures. During the data collection possibilities for feedbacks/clinical discussion of individual cases will be offered.
Assessments in the comparison group involve measures already implemented (from June 2017).
2021: Dataanalysis, discussion and presentation of results: Datacollection will be concluded and analyses of results proceeds.
2022: Project conclusion
Plan for dissemination of results:
Running information about the project with Norwegian summaries, key researchers and references to all publications will be available at the internet home site of the Research group for Personality Psychiatry in all phases of the project.
Three research publications are scheduled. Manuscripts will be submitted to international peer reviewed journals (open access publication). Research results will also be presented in relevant international/national conferences
When the project is concluded, the project group will arrange a conference for participating clinicians/institutions/organizations, evaluating the investigation, implications and further developments.
User involvement:
The project-group includes three members with relevant user experience, Thea Røstbakken, Mona Pettersen and Andrea Holst.
Ethical considerations The regional ethical committee (REC) has approved the investigator's application for ethical approval. REC reference number is: 2018/1124 A (REC South East).
- Conditions
- Self Harm, Personality Disorders, Psychosis, Developmental Disorder, PTSD, Cognitive Impairment
- Being tested
- Assessment of diagnoses, functioning and health services
- Keywords
- Selfharming behaviors
- Medical subject headings
- Self-Injurious Behavior, Personality Disorders, Psychotic Disorders, Developmental Disabilities, Stress Disorders, Post-Traumatic, Cognitive Dysfunction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Assessment of diagnoses, functioning and health servicesOther
Systematic differential diagnostics, assessment of psychosocial and personality functioning and treatment/ health services
| Study group | Role | What they receive |
|---|---|---|
| Inpatient cohort (Target group) | Inpatient at mental health centre/ psychiatric hospital due to severe self-harm. Duration > 4 weeks and/or > five admissions last year.
Assessment of diagnoses, functioning and health services Receives: Other: Assessment of diagnoses, functioning and health services | |
| Outpatient comparison cohort | Admitted to treatment within Norwegian Network of personality-focused treatment during 2017-2018.
Assessment of diagnoses, functioning and health services Receives: Other: Assessment of diagnoses, functioning and health services |
What is being measured
The primary outcome is the main question the study is designed to answer.
Psychiatric Disorders as assessed by M.I.N.I.plus
Diagnoses will be assessed by use of semistructured clinical interview: Mini International Neuropsychiatric Interview (M.I.N.I plus)
Measured: 2019-2021
Post Traumatic Stress Disorder as assessed by PTSD CL 5
Presence and severity of PTSD symptoms will be assessed by PTSD Checklist for DSM-5 (PTSD CL 5)
Measured: 2019-2021
Severity of psychiatric symptoms as assessed by PHQ
Severity of symptoms will be assessed by patient-reports based on the Patient Health Questionairre (PHQ)
Measured: 2019-2021
Screening for substance use disorder as assessed by AUDIT/DUDIT
Additional screening for substance abuse by self-report Alcohol/Drug use disorder identification test (AUDIT/DUDIT)
Measured: 2019-2021
Personality Disorders as assessed by SCID 5 PD
Diagnoses will be assessed by use of the Structured Clinical interview for Diagnoses of Personality Disorders according to DSM-5: SCID-5-PD
Measured: 2019-2021
Psychosocial functioning I as assessed by GAF
Global functioning will be assessed by use of the observer-rated Global assessment of functioning (GAF)
Measured: 2019-2021
Psychosocial functioning II as assessed by WSAS
Global functioning will be assessed by use of self-report: WOrk and Social adjustment Scale (WSAS)
Measured: 2019-2021
Learning disability screening as assessed by HASI
Learning disability will be assessed by use of Hayes Ability Screening Index (HASI)
Measured: 2019-2021
Autism spectrum screening as assessed by RAADS-R
Screening for autism will entail use of The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R)
Measured: 2019-2021
Overall personality functioning as assessed by SIPP-118
Assessment of personality functioning entails use of the Severity Indices for Personality Functioning (SIPP-118)
Measured: 2019-2021
Emotional regulation as assessed by DERS
Assessment of problems with emotional dysregulation entails use of Difficulties in emotional regulation scale (DERS)
Measured: 2019-2021
Aggressive behaviors as assessed by MOAS
Assessment of problems with aggressive outbursts or behaviors will be assessed by Items from the Modified Overt Aggression Scale (MOAS)
Measured: 2019-2021
Alexithymia as assessed by TAS-20
Assessment of aspects of affect consciousness will be assessed by the Toronto Alexithymia scale (TAS-20)
Measured: 2019-2021
Close relationships and attachment patterns as assessed by ECR
Assessment of capacities and maladaptive patterns in close relationships will be assessed by the inventory: Experiences in close relationships (ECR).
Measured: 2019-2021
Selfharming behaviors as assessed by LPC
Detailed assessment of selfharming behaviors will entail use of the interview: Lifetime Para suicide Count (LPC)
Measured: 2019-2021
Specialist mental health service utilization I as assessed by specific interview
Interview designed for this project for systematic assessment of the volume of service use last six months (number of outpatient consultations).
Measured: 2019-2021
Specialist mental health service utilization II as assessed by specific interview
Interview designed for this project for systematic assessment of the volume of service use last six months (number of inpatient (hospital) admissions).
Measured: 2019-2021
Specialist mental health service utilization III as assessed by specific interview
Interview designed for this project for systematic assessment of the volume of service use last six months (number of inpatient days in hospital).
Measured: 2019-2021
Specialist mental health service treatment as assessed by specific interview
Interview designed for this project for systematic assessment of type of treatment (category) received last six months.
Measured: 2019-2021
Welfare services as assessed by specific interview
Interview designed for this project for systematic assessment of type of welfare service (category) last six months.
Measured: 2019-2021
Age at first contact with specialist mental health services as assessed by specific interview
Age (years) at first contact with mental health services
Measured: 2019-2021
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Dec 2018
- Study start1 Oct 2019
- Primary completion1 Sep 2021
- Study completion1 Sep 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Self HarmStudies of the same condition, open and under way.
- More trials run by Oslo University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 1,640 participants (actual)
Sponsor and investigators
- Lead sponsor
- Oslo University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Extrastiftelsen, National Advisory Unit for Personality Psychiatry (NAPP), Research Group Personality Psychiatry, Network for personality-focused treatment, National Centre for Suicide Research and Prevention (NSSF), Regional Centre for Violence and Traumatic Stress (RVTS), Regional Centre for Early Intervention Psychosis (TIPS SØrØst), Regional collaborators and users
- Responsible party
- Principal investigator, Elfrida H Kvarstein, Oslo University Hospital
- Investigators
- Elfrida H Kvarstein, MD,PhD, Principal investigator, Oslo University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03768674
- Sponsor's protocol ID
- 2019/FO244009
- Other IDs
- 2018/1124
- Status last verified
- Jun 2024
- First submitted
- 11 Nov 2018
- Last updated
- 21 Jun 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- English Title: Extreme Challenges - Psychopathology, Treatment Organization and Experiences Among Psychiatric Inpatients With Severe Self-harming Behavior in Norway
- ClinicalTrials.gov ID
- NCT03768674
- Acronym / sponsor ID
- 2019/FO244009
- Conditions
- Self Harm, Personality Disorders, Psychosis, Developmental Disorder, PTSD, Cognitive Impairment
- Keywords
- Selfharming behaviors
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,640 participants (actual)
- Lead sponsor
- Oslo University HospitalUniversity, hospital or other
- Collaborators
- Extrastiftelsen, National Advisory Unit for Personality Psychiatry (NAPP), Research Group Personality Psychiatry, Network for personality-focused treatment, National Centre for Suicide Research and Prevention (NSSF), Regional Centre for Violence and Traumatic Stress (RVTS), Regional Centre for Early Intervention Psychosis (TIPS SØrØst), Regional collaborators and users
- Study start
- 1 Oct 2019 (actual)
- Primary completion
- 1 Sep 2021 (actual)
- Study completion
- 1 Sep 2021 (actual)
- First posted
- 7 Dec 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients who self-harm are a heterogeneous population. Outpatient treatments structured for borderline personality disorder are often recommended and hospitalization kept to a minimum. However, few studies have focused on the most severe, complex conditions with extreme suicide risk. A recent national investigation from Norway (2017) demonstrated a far larger cohort of extensively hospitalized inpatients with extreme self-harming behaviors than was expected (N=427) - identified in all health regions. Reported challenges were high-risk situations, severe medical sequelae, difficult collaborations across services, and uncertainty about psychiatric diagnoses.
Severe, often bizarre, self-harm is thus a major challenge for both patients and health services. In hospitals, safety measures can involve restrictions and involuntary regimes. As research on this target population is sparse, the current project seeks further understanding of complex conditions - psychopathology, treatment experiences and service collaboration.
The project is a national, multi-center cooperation including patients in psychiatric hospitals in all health regions. It is cross sectional. Data is based on diagnostic interviews, patients' self-reported symptoms and both patients and service providers treatment experiences. The inclusion period for inpatients (N=300) and a comparison sample of outpatients (N=300) is one year.
The target group is inpatients with extreme hospitalization and severe self-mutilation. A comparison group is patients with personality pathology attending outpatient treatments. Recruitment is across health regions.
Aim 1: Investigate psychopathology of patients in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 2: Investigate personality functioning in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 3: a) Investigate health service use in the target population and compare to a clinical sample admitted to outpatient treatment.
- Investigate treatment experiences and health service collaborations in the target population.
The project will provide rational for future preventive treatment interventions
Detailed description
Design: A cross-sectional investigation. The inclusion period will be one year.
The target group: Patients admitted to inpatient units (adult psychiatry, mental health centres or hospitals) due to risk of severe self-harm. The duration of admissions are either more than 4 weeks and/or patients have had more than five admissions in the preceding year.
The comparison group is a collaboration with the Norwegian Network of personality-focused treatments and includes clinical data from 19 outpatient units within specialist mental health services across Norway (baseline data for 300 patients admitted to treatment during 2017-2018).
Sample size: An inclusion of N=300 patients in the target Group and comparison group
Assessments: The assessment battery combines therapist administered interviews and patient self-report measures to provide a broad differential-diagnostic evaluation and information about treatment and health-service collaborations. It also includes therapist-reports.
Psychopathology: Assessment of psychiatric disorders includes interviews for symptom disorders (MINI), personality traits and disorders (SCID-5-PD, and observer-evaluated global functioning (GAF) administered in both the target and the comparison group. Assessment of the target group will additionally include a screening interview on cognitive functioning (Hayes Ability Screening Index, HASI, specific approval has been given), self-report screening of autism (Ritvo Autisme Asperger Diagnoseskjema - Revidert RAADS-R), and a detailed interview on psychosis (questions from MINI plus).
General, social and personality functioning: The assessment battery includes a combination of well-established, (no cost) self-report measures covering overall functioning, symptoms, trauma, personality functioning and maladaptive behaviors. These will be administered in both the target and the comparison group. More details on assessment battery can be given on request to PI.
Self-harming behaviors: Self-report on self-harming behaviors and suicide attempts last 6 months are included. Assessment of the target group will additionally include a more detailed interview of self-harming behaviors adapted for Norwegian studies (Lifetime Para suicide Count).
Service use, treatment experiences, and health service collaborations: Assessment of previous treatments, age first time, and contact with child/adolescent psychiatry (self-report, both the target and the comparison group), and a detailed interview on medication, treatments, primary health care and welfare services last 6 months (specially designed interview, both target and comparison group). In addition, for the target group, questions about involuntary and restrictive regimes, treatment involvement, confidence, alliance and collaboration within and across health services are included (patient and therapist reported).
Research collaborators:
The PhD candidate will follow the PhD educationary program at the University of Oslo. Main supervisor is also Principle Investigator (E.H.Kvarstein), and co supervisor (G.Pedersen) heads the Network collaboration. The PhD candidate will join the national project group and be an associated member of the Research group for Personality Psychiatry.
The national project group is central in all phases; design, preparations, implementation procedures, evaluation, and presentations of results. It covers all health regions, relevant research environments, clinicians and users. It includes: Middle HR: T.Torgersen, PhD, Western HR: T.Tveit, MD. Southeastern HR: P.A.Ringen, PhD, P.Danielsen, MA, C.A.Sveen (MA), Tore Buer (MD). Northern HR: H.Tvete, MD, T.Høifødt, PhD. National Centre, Suicide Research and Prevention: F.Walby,MA, R.K.Ramleth, MD (BUP). Regional Centre, Violence and Traumatic Stress: I.Lunde, MA. Early intervention Psychosis: K.L.Romm, PhD. Personality Psychiatry National Advisory Unit: Ø.Urnes,MD. User experience: T.Røstbakken, M.Pettersen, A.Holst.
The Research group for personality psychiatry (University of Oslo/Oslo University Hospital) is an active, well-established research group with engagement in national and international research collaborations specializing on personality pathology and clinical research.
The principle investigator (PI) and main supervisor of this project, E.H.Kvarstein, associate professor, University of Oslo/ Head senior consultant, Section for Personality Psychiatry, Oslo University Hospital, is head of the Research group of personality psychiatry.
The Norwegian Network for personality-focused treatment is a well-established collaboration aiming to ensure clinical quality, systematic treatment evaluation and generate data for clinical research (anonymous data collection). The Network was established in 1993 and currently includes 19 outpatient treatment teams across Norway for patients with personality disorder. Approximately 400 patients are admitted to treatments within the Network each year (mean treatment duration: 2 years). The Network provides systems for patient assessment and progress evaluation, systematic feedback reports on clinical outcomes and supervision/seminars on diagnostic assessment and treatment. The main (ongoing) research project in the Network is a multi-centre feasibility investigation of evidence-based treatment for personality disorder (started in 2017) aiming to include longitudinal treatment data for 500 patients.
"Extreme challenges" is a research collaboration between the national project group and the Network. Baseline data from the multi-centre project constitute the outpatient comparison group in "Extreme challenges" (300 patients, admitted to outpatient treatment in 2017-18, data available in 2020).
Cosupervisor in the PhD project, head of the Network, is senior researcher Geir Pedersen. He is affiliated within the Section for Personality Psychiatry, Oslo University Hospital and the University of Oslo. He is a member of the research group.
Norwegian National Advisory Unit on Personality Psychiatry (NAPP) is the initiator of the current project and the organizer of the national project group. With the establishment of an expert user panel (recruiting users from the whole country), NAPP has also had an active role establishing user engagement in this project.
Plan for activities - practical implementation of the cross sectional investigation: The national project group has already completed a preliminary screening investigation, first publication, and designed the current project. The project group is currently preparing practical implementation of the project (mobilizing regional collaborators, local resource groups and finalizing ethic approvals and systems for data collection).
2018/19: Preparation: Regional preparatory seminars for local clinicians and all collaborators are scheduled to autumn 2019.
2019/2020: Data collection: Assessments of the target population will be performed at the inpatient institutions by local clinicians qualified for diagnostic procedures. During the data collection possibilities for feedbacks/clinical discussion of individual cases will be offered.
Assessments in the comparison group involve measures already implemented (from June 2017).
2021: Dataanalysis, discussion and presentation of results: Datacollection will be concluded and analyses of results proceeds.
2022: Project conclusion
Plan for dissemination of results:
Running information about the project with Norwegian summaries, key researchers and references to all publications will be available at the internet home site of the Research group for Personality Psychiatry in all phases of the project.
Three research publications are scheduled. Manuscripts will be submitted to international peer reviewed journals (open access publication). Research results will also be presented in relevant international/national conferences
When the project is concluded, the project group will arrange a conference for participating clinicians/institutions/organizations, evaluating the investigation, implications and further developments.
User involvement:
The project-group includes three members with relevant user experience, Thea Røstbakken, Mona Pettersen and Andrea Holst.
Ethical considerations The regional ethical committee (REC) has approved the investigator's application for ethical approval. REC reference number is: 2018/1124 A (REC South East).
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Inpatient cohort (Target group) | – | Other: Assessment of diagnoses, functioning and health servicesInpatient at mental health centre/ psychiatric hospital due to severe self-harm. Duration > 4 weeks and/or > five admissions last year. Assessment of diagnoses, functioning and health services |
| Outpatient comparison cohort | – | Other: Assessment of diagnoses, functioning and health servicesAdmitted to treatment within Norwegian Network of personality-focused treatment during 2017-2018. Assessment of diagnoses, functioning and health services |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- The target population is patients with extensive hospitalization due to selfharming behaviors
Key inclusion criteria (3 listed)
- Admitted to inpatient units (adult psychiatry, mental health centres or hospitals) due to risk of severe self-harm.
- Duration of admissions either > 4 weeks and/or > five admissions preceding year.
- Assessed for outpatient treatment within the outpatient Network
Key exclusion criteria (2 listed)
- Not inpatients at a psychiatric, adult (18-60 yrs) institution
- Assessed but not admitted to outpatient treatment within the Network
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Assessment of diagnoses, functioning and health servicesSystematic differential diagnostics, assessment of psychosocial and personality functioning and treatment/ health services | Other | Inpatient cohort (Target group), Outpatient comparison cohort |
Primary outcome
Psychiatric Disorders as assessed by M.I.N.I.plus
Time frame: 2019-2021
Diagnoses will be assessed by use of semistructured clinical interview: Mini International Neuropsychiatric Interview (M.I.N.I plus)
Post Traumatic Stress Disorder as assessed by PTSD CL 5
Time frame: 2019-2021
Presence and severity of PTSD symptoms will be assessed by PTSD Checklist for DSM-5 (PTSD CL 5)
Severity of psychiatric symptoms as assessed by PHQ
Time frame: 2019-2021
Severity of symptoms will be assessed by patient-reports based on the Patient Health Questionairre (PHQ)
Screening for substance use disorder as assessed by AUDIT/DUDIT
Time frame: 2019-2021
Additional screening for substance abuse by self-report Alcohol/Drug use disorder identification test (AUDIT/DUDIT)
Personality Disorders as assessed by SCID 5 PD
Time frame: 2019-2021
Diagnoses will be assessed by use of the Structured Clinical interview for Diagnoses of Personality Disorders according to DSM-5: SCID-5-PD
Psychosocial functioning I as assessed by GAF
Time frame: 2019-2021
Global functioning will be assessed by use of the observer-rated Global assessment of functioning (GAF)
Psychosocial functioning II as assessed by WSAS
Time frame: 2019-2021
Global functioning will be assessed by use of self-report: WOrk and Social adjustment Scale (WSAS)
Learning disability screening as assessed by HASI
Time frame: 2019-2021
Learning disability will be assessed by use of Hayes Ability Screening Index (HASI)
Autism spectrum screening as assessed by RAADS-R
Time frame: 2019-2021
Screening for autism will entail use of The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R)
Overall personality functioning as assessed by SIPP-118
Time frame: 2019-2021
Assessment of personality functioning entails use of the Severity Indices for Personality Functioning (SIPP-118)
Emotional regulation as assessed by DERS
Time frame: 2019-2021
Assessment of problems with emotional dysregulation entails use of Difficulties in emotional regulation scale (DERS)
Aggressive behaviors as assessed by MOAS
Time frame: 2019-2021
Assessment of problems with aggressive outbursts or behaviors will be assessed by Items from the Modified Overt Aggression Scale (MOAS)
Alexithymia as assessed by TAS-20
Time frame: 2019-2021
Assessment of aspects of affect consciousness will be assessed by the Toronto Alexithymia scale (TAS-20)
Close relationships and attachment patterns as assessed by ECR
Time frame: 2019-2021
Assessment of capacities and maladaptive patterns in close relationships will be assessed by the inventory: Experiences in close relationships (ECR).
Selfharming behaviors as assessed by LPC
Time frame: 2019-2021
Detailed assessment of selfharming behaviors will entail use of the interview: Lifetime Para suicide Count (LPC)
Specialist mental health service utilization I as assessed by specific interview
Time frame: 2019-2021
Interview designed for this project for systematic assessment of the volume of service use last six months (number of outpatient consultations).
Specialist mental health service utilization II as assessed by specific interview
Time frame: 2019-2021
Interview designed for this project for systematic assessment of the volume of service use last six months (number of inpatient (hospital) admissions).
Specialist mental health service utilization III as assessed by specific interview
Time frame: 2019-2021
Interview designed for this project for systematic assessment of the volume of service use last six months (number of inpatient days in hospital).
Specialist mental health service treatment as assessed by specific interview
Time frame: 2019-2021
Interview designed for this project for systematic assessment of type of treatment (category) received last six months.
Welfare services as assessed by specific interview
Time frame: 2019-2021
Interview designed for this project for systematic assessment of type of welfare service (category) last six months.
Age at first contact with specialist mental health services as assessed by specific interview
Time frame: 2019-2021
Age (years) at first contact with mental health services
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jun 2024.
- Individual participant dataSharing planned: No
Related trials for Self Harm
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Elfrida H Kvarstein, MD,PhD principal investigator
Oslo University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Self Harm and Personality Disorders, run by Oslo University Hospital at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Psychiatric Disorders as assessed by M.I.N.I.plus (time frame: 2019-2021). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2024.